A study by Belal Al-Husein et al. revealed that micrometastasis in prostate cancer could be inhibited by blocking integrin αVß3 and ICAM-1, thus implying its function in overcoming the endothelial barrier and allowing hematogenous metastasis [58]. Here, ICAM1 is linked to prostate cancer.